NewslettersHuman Immunology NewsTargeting the Immunoglobulin IGSF9 Enhances Anti-Tumor T Cell Activity and Sensitivity to Anti-PD-1 ImmunotherapyBy Bob - August 1, 20230280Researchers identified increased expression of the adhesion molecule immunoglobulin superfamily member 9 (IGSF9) in tumor cells and tumor-infiltrating immune cells across multiple cancer types.[Cancer Research]Abstract